However, Danielsson et al. [12] reported that the development of PAD in patients suffering from diabetes was not associated with the polymorphism of the gene for IL-6, and that the concentration of inflammatory markers was normal in the lower clinical stage of this disease. Here, IL6 is linked to diabetes mellitus.